company background image
OMIC

Singular Genomics Systems NasdaqGS:OMIC Stock Report

Last Price

US$1.92

Market Cap

US$137.1m

7D

-3.0%

1Y

-83.3%

Updated

05 Dec, 2022

Data

Company Financials +
OMIC fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

OMIC Stock Overview

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine.

Singular Genomics Systems, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Singular Genomics Systems
Historical stock prices
Current Share PriceUS$1.92
52 Week HighUS$12.43
52 Week LowUS$1.82
Beta0
1 Month Change-16.52%
3 Month Change-29.15%
1 Year Change-83.28%
3 Year Changen/a
5 Year Changen/a
Change since IPO-92.54%

Recent News & Updates

Singular Genomics cut to Neutral at UBS on delays for sequencer shipments

Aug 17

Recent updates

Shareholder Returns

OMICUS Life SciencesUS Market
7D-3.0%1.7%1.1%
1Y-83.3%-25.9%-17.6%

Return vs Industry: OMIC underperformed the US Life Sciences industry which returned -25.2% over the past year.

Return vs Market: OMIC underperformed the US Market which returned -14.9% over the past year.

Price Volatility

Is OMIC's price volatile compared to industry and market?
OMIC volatility
OMIC Average Weekly Movement12.6%
Life Sciences Industry Average Movement11.4%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: OMIC is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week.

Volatility Over Time: OMIC's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2016269Drew Spaventahttps://singulargenomics.com

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution.

Singular Genomics Systems, Inc. Fundamentals Summary

How do Singular Genomics Systems's earnings and revenue compare to its market cap?
OMIC fundamental statistics
Market CapUS$137.08m
Earnings (TTM)-US$89.54m
Revenue (TTM)n/a

0.0x

P/S Ratio

-1.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
OMIC income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$89.54m
Earnings-US$89.54m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.25
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio3.6%

How did OMIC perform over the long term?

See historical performance and comparison